Spots Global Cancer Trial Database for Post Marketing Surveillance Study for ONIVYDE® in South Korea
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post Marketing Surveillance Study for ONIVYDE® in South Korea
Official Title: Post Marketing Surveillance Study for ONIVYDE® in South Korea
Study ID: NCT03446872
Conditions
Study Description
Brief Summary: The purpose of this study is to characterize the safety of ONIVYDE when used under standard clinical practice in South Korea; and to describe effectiveness in patients receiving ONIVYDE in combination with 5-fluorouracil (5-FU) and leucovorin for the treatment of metastatic pancreatic cancer under standard clinical care in South Korea.
Detailed Description:
Keywords
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Konyang University Hospital, Daejeon, , Korea, Republic of
National Cancer Center, Gyeonggi-do, , Korea, Republic of
Severance Hospital, Yonsei University Health System - Gastroenterology, Seoul, , Korea, Republic of
Severance Hospital, Yonsei University Health System - Oncology, Seoul, , Korea, Republic of
ASAN Medical Center, Seoul, , Korea, Republic of
Gangnam Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of
Samsung Medical Center - Oncology, Seoul, , Korea, Republic of
The Catholic University of Korea Seoul St.Mary's Hospital, Seoul, , Korea, Republic of
Korea University Guro Hospital, Seoul, , Korea, Republic of
Ajou University Hospital, Suwon, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
